Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chasing mutations in the epidermal growth factor in lung cancer.

× No keyword cloud information.

9 in total

1. PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.

Authors: Matthew P Stokes; Charles L Farnsworth; Albrecht Moritz; Jeffrey C Silva; Xiaoying Jia; Kimberly A Lee; Ailan Guo; Roberto D Polakiewicz; Michael J Comb
Journal: Mol Cell Proteomics Date: 2012-02-09 Impact factor: 5.911

2. CanProVar: a human cancer proteome variation database.

Authors: Jing Li; Dexter T Duncan; Bing Zhang
Journal: Hum Mutat Date: 2010-03 Impact factor: 4.878

3. The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.

Authors: Nadiyah Kazmi; Diana C Márquez-Garbán; Lilia Aivazyan; Nalo Hamilton; Edward B Garon; Lee Goodglick; Richard J Pietras
Journal: Lung Cancer Manag Date: 2012-12

Review 4. Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling.

Authors: Bin Fang; Eric B Haura; Keiran S Smalley; Steven A Eschrich; John M Koomen
Journal: Biochem Pharmacol Date: 2010-03-31 Impact factor: 5.858

5. Synthesis of 4,5-Dihydro-1H-[1,2]dithiolo[3,4-c]quinoline-1-thione Derivatives and Their Application as Protein Kinase Inhibitors.

Authors: Svetlana M Medvedeva; Khidmet S Shikhaliev
Journal: Molecules Date: 2022-06-23 Impact factor: 4.927

6. Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.

Authors: J Lin; T Sun; L Ji; W Deng; J Roth; J Minna; R Arlinghaus
Journal: Oncogene Date: 2007-05-07 Impact factor: 9.867

7. Global connectivity of hub residues in Oncoprotein structures encodes genetic factors dictating personalized drug response to targeted Cancer therapy.

Authors: Venky Soundararajan; Murali Aravamudan
Journal: Sci Rep Date: 2014-12-03 Impact factor: 4.379

8. Association of EGFR 1 Gene Alteration and their Association with Lung Adenocarcinoma Patients

Authors: Mirza Masroor Ali Beg; Samer Riyadh Fahdil; Prasant Yadav; Kamla kant Shukla; Anant Mohan; Alpana Saxena
Journal: Asian Pac J Cancer Prev Date: 2019-03-26

9. PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study.

Authors: Norma A Hernández; Elma Correa; Esther P Avila; Teresa A Vela; Víctor M Pérez
Journal: J Transl Med Date: 2009-06-18 Impact factor: 5.531

9 in total